These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 498955)

  • 1. [Possibilities of treatment reduction in Hodgkin's disease (author's transl)].
    Teillet F; Delbrück H; Bayle-Weisgerber C; Andrieu JM; Clot P
    Dtsch Med Wochenschr; 1979 Oct; 104(40):1405-9. PubMed ID: 498955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possibilities of treatment of reduction in Hodgkin's disease. III. Can polychemotherapy when combined with radiotherapy of localised stages be reduced? (author's transl)].
    Teillet F; Delbrück H; Bayle-Weisgerber C; Asselain B; Lelièvre P; Bernard J
    Dtsch Med Wochenschr; 1981 May; 106(18):566-70. PubMed ID: 7215184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A trial of combined chemotherapy and radiotherapy for stage IV Hodgkin's disease with initial lung involvement (author's transl)].
    Weh HJ; Andrieu JM; Bernard J
    Dtsch Med Wochenschr; 1978 Nov; 103(46):1825-9. PubMed ID: 710303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects and therapy of stage III Hodgkin's disease (author's transl)].
    Weh HJ; Andrieu JM
    MMW Munch Med Wochenschr; 1980 Jun; 122(25):932-4. PubMed ID: 6772941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Laparotomy and splenectomy in Hodgkin's disease (author's transl)].
    Vaarik HM
    Arch Geschwulstforsch; 1978; 48(5):416-8. PubMed ID: 747514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hodgkin's disease: the value of prognostic criteria and of the combination of radiotherapy and chemotherapy in localised lymphoid stages (I and II). 94 patients undergoing laparotomy (author's transl)].
    Bernadou A; Blanc CM; James JM; Dao C; Zittoun R; Bilski-Pasquier G
    Nouv Presse Med; 1978 Mar; 7(10):807-12. PubMed ID: 643545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibilities of radiation-dose reduction in the treatment of Hodgkin's disease. I. Exclusion of the mediastinum from the radiation field in primary high-cervical or infradiaphragmatic involvement and stage I or II (author's transl)].
    Teillet E; Delbrück H; Bayle-Weisgerber C; Andrieu JM; Asselain B; Dana M; Bernard J
    Dtsch Med Wochenschr; 1979 Sep; 104(39):1369-74. PubMed ID: 477568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical restaging of Hodgkin's disease.
    Goodman GE; Jones SE; Villar HV; Silverstein ME; Dabich L; Newcome SR
    Cancer Treat Rep; 1982 Apr; 66(4):751-7. PubMed ID: 7074645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment.
    Berkowicz M; Rath P; Aghai E; Many A; Ben-Bassat I; Hulu N; Ramot B; Brenner H
    Isr J Med Sci; 1978 Dec; 14(12):1275-82. PubMed ID: 748241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D; Greenberg M; Fitzgerald A
    Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary and secondary exploratory laparotomy and splenectomy in Hodgkin's disease (author's transl)].
    Bruntsch U; Beersiek F; Eigler FW; Grub R; Van Lessen H; Löhr GW; Musshoff K; Schmidt CG; Slanina J
    Dtsch Med Wochenschr; 1977 Dec; 102(49):1799-804. PubMed ID: 590105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exploratory laparotomy and splenectomy in lymphogranulomatosis (author's transl)].
    Neidhardt B; Hartwich G; Schwemmle K; Hermanek P; Seiler G
    Dtsch Med Wochenschr; 1975 Jul; 100(28):1487-92. PubMed ID: 1137945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Splenectomy in Hodgkin's disease--indication and results (author's transl)].
    Keinert K; Kober V; Reichel J; Rüdiger KD; Schumann E; Trux F
    Arch Geschwulstforsch; 1976; 46(4):311-5. PubMed ID: 971047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-gonadic complications of chemoradiotherapy in Hodgkin's disease. A study of eighty-three patients (author's transl)].
    Bolla M; Sotto JJ; Barjhoux R; Kolodie H; Vincent F; Michallet M; Sarrazin R; Vrousos C; Hollard D
    Sem Hop; 1982 Jan; 58(4):204-8. PubMed ID: 6280286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
    Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
    [No Abstract]   [Full Text] [Related]  

  • 18. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of procarbazine in the chemotherapy of Hodgkin's disease--a report of the Cooperative Therapy Study DAL-HD-85].
    Schellong G; Hörnig I; Brämswig J; Bökkerink JP; Steinhoff A; Ludwig R; Niethammer D; Reiter A; von Lengerke HJ; Heinecke H
    Klin Padiatr; 1988; 200(3):205-13. PubMed ID: 3062257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.